Clinical Trial Update: Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating nivolumab with gemcitabine/cisplatin or with ipilimumab for advanced unresectable biliary tract cancer has completed, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Biliary Tract Neoplasms

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Biliary Tract Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2021-08-10